The industry focused on extending humans' lives beyond the normal lifespan could be worth at least $600 billion in 2025 and the average lifespan could hit 100 years before we know it, according to a new report.
CNBC reported on a study performed by two analysts at Bank of America Merrill Lynch that found the race to help people live longer is moving at top speed.
There are several pieces to the puzzle, including genomics, artificial intelligence, food, and medicine. Companies such as Illumina, Alphabet, and Novartis are working to solve the mystery of how to use science to increase lifespan.
"Medical knowledge will double every 73 days by 2020 vs. every 3.5 (years) in 2010, and genomic sequencing costs have fallen 99.999% since 2003," analysts Felix Tran and Haim Israel wrote in their report. "This has enabled a new frontier in precision medicine to further extend life expectancy, heralding a 'techmanity' (technology meets humanity) revolution."
The technology could soon be developed to push the average lifespan over 100, Tran and Israel found.
The average lifespan in the United States is just under 79 years.
According to a report last month, people who live to 105 have a good chance to continue living after that because of how cells work.
Another report last fall claimed that the first human to live to 1,000 years might already be alive.
© 2023 Newsmax. All rights reserved.